Literature DB >> 25536342

Reprogramming cellular signaling machinery using surface-modified carbon nanotubes.

Yi Zhang1, Ling Wu, Cuijuan Jiang, Bing Yan.   

Abstract

Nanoparticles, such as carbon nanotubes (CNTs), interact with cells and are easily internalized, causing various perturbations to cell functions. The mechanisms involved in such perturbations are investigated by a systematic approach that utilizes modified CNTs and various chemical-biological assays. Three modes of actions are (1) CNTs bind to different cell surface receptors and perturb different cell signaling pathways; (2) CNTs bind to a receptor with different affinity and, therefore, strengthen or weaken signals; (3) CNTs enter cells and bind to soluble signaling proteins involved in a signaling pathway. Understanding of such mechanisms not only clarifies how CNTs cause cytotoxicity but also demonstrates a useful method to modulate biological/toxicological activities of CNTs for their various industrial, biomedical, and consumer applications.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25536342     DOI: 10.1021/tx500480d

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  4 in total

1.  Quantitation of cell-associated carbon nanotubes: selective binding and accumulation of carboxylated carbon nanotubes by macrophages.

Authors:  Ruhung Wang; Michael Lee; Karina Kinghorn; Tyler Hughes; Ishwar Chuckaree; Rishabh Lohray; Erik Chow; Paul Pantano; Rockford Draper
Journal:  Nanotoxicology       Date:  2018-05-26       Impact factor: 5.913

2.  Screening Small Metabolites from Cells as Multifunctional Coatings Simultaneously Improves Nanomaterial Biocompatibility and Functionality.

Authors:  Anqi Sun; Zhan Ban; Li Mu; Xiangang Hu
Journal:  Adv Sci (Weinh)       Date:  2018-05-23       Impact factor: 16.806

3.  The combination of MnO2@Lipo-coated gefitinib and bevacizumab inhibits the development of non-small cell lung cancer.

Authors:  Jisong Zhang; Li Xu; Huihui Hu; Enguo Chen
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.419

4.  TRIM66 Promotes Malignant Progression of Non-Small-Cell Lung Cancer Cells via Targeting MMP9.

Authors:  Yufen Xu; Qi Yang; Zhixian Fang; Xiaoli Tan; Ming Zhang; Wenyu Chen
Journal:  Comput Math Methods Med       Date:  2022-07-21       Impact factor: 2.809

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.